BIOM-48. PTEN MUTATIONS PREDICT BENEFIT FROM TUMOR-TREATING FIELDS THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA

BACKGROUND: Glioblastoma IDH-wildtype (GBM-IDH-WT) recurs despite the standard of care which includes surgical resection and concurrent chemoradiotherapy. Optimal treatment for recurrent GBM-IDH-WT (rGBM) is not standardized and multiple therapeutic approaches are utilized. Clinical trials have show...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Dono, Antonio, Mitra, Sonali, Takayasu, Takeshi, Zhu, Jay-Jiguang, Tandon, Nitin, Esquenazi, Yoshua, Ballester, Leomar Y
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Biomarkers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650355/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.045
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller